Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04201041
Other study ID # PNB
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 1, 2018
Est. completion date March 25, 2020

Study information

Verified date April 2020
Source South Egypt Cancer Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Superficial dyspareunia represents a major health problem especially for the newly wed couples. Pulsed radiofrequency for pudendal nerve is a non-neurolytic neuromodulatory method that is effective in relief of this type of pain. Objectives: to evaluate the efficacy of bilateral pudendal nerve fluoroscopic guided pulsed radiofrequency in treatment of intractable non-organic dyspareunia, and compare between trans-gluteal and transvaginal approaches regarding patient comfort and satisfaction.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date March 25, 2020
Est. primary completion date March 20, 2020
Accepts healthy volunteers No
Gender All
Age group 16 Years to 46 Years
Eligibility Inclusion Criteria:

- women aged between 16 and 46 years and from a near vicinity to our facility to make her available for follow-up

Exclusion Criteria:

- We had excluded women with any abnormality in the transvaginal US guided imagining, or those with any evidence of local gynecological abnormalities on examination. Meanwhile, we had excluded those women with infection at site of injection, coagulopathy or other bleeding diathesis, pre-existing neurologic deficit in the targeted region, those with history of chronic opioid use and women who refused to participate in the study

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
pudendal nerve pulsed radiofrequency
received pudendal nerve pulsed radiofrequency through trans-vaginal approach or trans-gluteal approach

Locations

Country Name City State
Egypt South Egypt Cancer Institute, Assiut University, Arab Republic of Egypt Assiut

Sponsors (1)

Lead Sponsor Collaborator
South Egypt Cancer Institute

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary change in Numerical rating scale 0 no pain and 10 maximum pain baseline reading -1 day reading-3 days postoperative reading
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06142851 - Management of Women With Superficial Dyspareunia